Showing results (51-60 of 142) with videos related to

Sort By:
Pageof 15
Medical Engineering & Physics|November 28, 2009
Can an accelerometer enhance the utility of the Timed Up & Go Test when evaluating patients with Parkinson's disease?Aner Weiss, Talia Herman, Meir Plotnik, et al.
Neurology|August 24, 2012
Lower cognitive performance in healthy G2019S LRRK2 mutation carriersAvner Thaler, Anat Mirelman, Tanya Gurevich, et al.
Neuroepidemiology|February 18, 2021
Interrelationships between Survival, Sex, and Blood Pressure in Patients with Multiple System AtrophyTanya Gurevich, Ludmila Merkin, Alina Rozenberg, et al.
CNS & Neurological Disorders Drug Targets|January 22, 2025
Comparison of Guided and Unguided Botulinum Injections for Cervical Dystonia: EMG, Ultrasound, and Anatomic LandmarksVered Livneh, Achinoam Faust-Socher, Mikhal E Cohen, et al.
Parkinsonism & Related Disorders|November 5, 2013
Parkinson's disease patients first treated at age 75 years or older: a comparative studyChava Peretz, Orly Chillag-Talmor, Shai Linn, et al.
Journal of Parkinson'S Disease|August 14, 2013
Use of a refined drug tracer algorithm to estimate prevalence and incidence of Parkinson's disease in a large israeli populationOrly Chillag-Talmor, Nir Giladi, Shai Linn, et al.
Archives of Neurology|January 11, 2012
Association of sequence alterations in the putative promoter of RAB7L1 with a reduced parkinson disease riskZiv Gan-Or, Anat Bar-Shira, Dvir Dahary, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 6, 2018
Survival rates among Parkinson's disease patients who carry mutations in the LRRK2 and GBA genesAvner Thaler, Tal Kozlovski, Tanya Gurevich, et al.
Journal of Neurology|February 21, 2023
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: long-term results from COSMOSAlfonso Fasano, Rocío García-Ramos, Tanya Gurevich, et al.
Brain Imaging and Behavior|July 5, 2018
Altered reward-related neural responses in non-manifesting carriers of the Parkinson disease related LRRK2 mutationAvner Thaler, Tal Gonen, Anat Mirelman, et al.
Pageof 15